Come up with a name for your new list and we'll add to it:
AVANT Immunotherapeutics was acquired by
Celldex Therapeutics on March 05, 2008.
Avant develops and markets vaccines for underserved markets. The company is developing a broad portfolio of vaccines addressing a wide range of applications including bacterial and viral diseases, car…